Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.35
+0.05 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
11.39
+0.04 (0.35%)
After-hours: Mar 9, 2026, 5:26 PM EDT

Keros Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
87.01-187.35-152.99-104.68-58.74
Upgrade
Depreciation & Amortization
1.511.230.820.670.38
Upgrade
Loss (Gain) From Sale of Assets
-0.01-00.010.05
Upgrade
Stock-Based Compensation
28.734.8728.7618.6811.72
Upgrade
Other Operating Activities
2.411.821.550.940.52
Upgrade
Change in Accounts Receivable
-0.83-2.6-0.1418-18
Upgrade
Change in Accounts Payable
-3-0.251.61-0.411.49
Upgrade
Change in Income Taxes
-2.25----
Upgrade
Change in Other Net Operating Assets
-6.04-8.59-4.12-3.280.45
Upgrade
Operating Cash Flow
107.51-160.87-124.51-70.06-62.15
Upgrade
Capital Expenditures
-1.55-1.93-2.46-1.24-1.02
Upgrade
Investing Cash Flow
-1.55-1.93-2.46-1.24-1.02
Upgrade
Issuance of Common Stock
0.29392.28179.05120.428.55
Upgrade
Repurchase of Common Stock
-378.9----
Upgrade
Other Financing Activities
0.14-0.45-0.09-0.09-
Upgrade
Financing Cash Flow
-378.47391.82178.96120.3128.55
Upgrade
Net Cash Flow
-272.52229.0251.9849.01-34.62
Upgrade
Free Cash Flow
105.95-162.8-126.97-71.3-63.17
Upgrade
Free Cash Flow Margin
43.41%-4585.91%-84087.42%--314.29%
Upgrade
Free Cash Flow Per Share
2.80-4.35-4.31-2.83-2.71
Upgrade
Cash Income Tax Paid
7.15----
Upgrade
Levered Free Cash Flow
66.24-108.31-81.25-33.84-39.48
Upgrade
Unlevered Free Cash Flow
66.24-108.31-81.25-33.84-39.48
Upgrade
Change in Working Capital
-12.11-11.44-2.6514.31-16.07
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.